Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Twist Bioscience Corporation (TWST) had Free Cash Flow of $-68.88M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$118.38M |
|
$-35.05M |
|
$55.92M |
|
$62.45M |
|
$154.66M |
|
$-36.28M |
|
$1.54M |
|
$-34.74M |
|
$-34.74M |
|
$-35.05M |
|
$-35.05M |
|
$-35.05M |
|
$-35.05M |
|
$-36.28M |
|
$-29.50M |
|
62.40M |
|
62.40M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$321.30M |
|
$111.89M |
|
$351.14M |
|
$672.44M |
|
$120.25M |
|
$15.00M |
|
$106.44M |
|
$226.70M |
|
$445.74M |
|
$350.81M |
|
$445.74M |
|
62.67M |
|
| Cash Flow Statement Financials | |
$-41.26M |
|
$-32.84M |
|
$8.22M |
|
$185.43M |
|
$119.57M |
|
$-65.86M |
|
$50.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.67 |
|
-- |
|
-- |
|
0.03 |
|
0.03 |
|
52.76% |
|
-30.65% |
|
-30.65% |
|
-- |
|
-29.35% |
|
-29.61% |
|
|
Free Cash Flow |
$-68.88M |
-- |
|
-- |
|
-- |
|
0.18 |
|
1.59 |
|
1.82 |
|
49.46 |
|
-7.86% |
|
-9.99% |
|
-5.21% |
|
-7.61% |
|
$7.11 |
|
$-1.10 |
|
$-0.66 |
|